Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

9 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Lung Cancer NCT00632853 Treatment - CALGB: 30610 Treatment and Response Form - 2688627v1.0 - CALGB: 30610 Treatment and Response Form

- 08/01/15 - 1 modulo, 5 itemgroups, 35 elementi, 1 linguaggio
Itemgroups: Header, Survival Date, Treatment Data, Response Data, Footer
CALGB: 30610 Treatment and Response Form Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3C3834F7-372A-2795-E044-0003BA3F9857

Lung Cancer NCT00049543 Response - Form 9 - Relapse/ Progressive Disease Report - 2034459v3.0 - Form 9 - Relapse/ Progressive Disease Report

- 09/01/15 - 1 modulo, 8 itemgroups, 50 elementi, 2 lingue
Itemgroups: 1. PATIENT INFORMATION, Radiology, 3. DISEASE STATUS, NCIC CTG use only, 4. RECURRENCE TABLE, 5. TREATMENT PLAN , 6. COMMENTS, 8. INVESTIGATOR SIGNATURE
Form 9 - Relapse/ Progressive Disease Report Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A06B0201-DAB9-5179-E034-080020C9C0E0

Response - PHASE II LUNG CANCER ¿ BASELINE SOLID TUMOR EVALUATION FORM - 2400961v1.0 - PHASE II LUNG CANCER ¿ BASELINE SOLID TUMOR EVALUATION FORM

- 09/01/15 - 1 modulo, 5 itemgroups, 28 elementi, 1 linguaggio
Itemgroups: CRF Header, Form Administration, Target Lesion(s) Baseline Evaluation , Nontarget Lesion(s) Baseline Evaluation, Comments
Phase II Consortium - PHASE II LUNG CANCER - BASELINE SOLID TUMOR EVALUATION FORM Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FFA78C21-8B29-096C-E034-0003BA3F9857

SOUTHWEST ONCOLOGY GROUP LUNG CARCINOMA FIRST SITE(S) OF PROGRESSION OR RELAPSE FORM NCT00045162

- 09/06/15 - 1 modulo, 2 itemgroups, 11 elementi, 1 linguaggio
Itemgroups: Header, Comments
SOUTHWEST ONCOLOGY GROUP LUNG CARCINOMA FIRST SITE(S) OF PROGRESSION OR RELAPSE FORM NCT00045162 S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=001AFD84-A62B-538E-E044-0003BA3F9857

Lung Cancer NCT01336894 Response - ACOSOG-Z4099 Pretreatment RECIST Measurement Form (Arm 2) - 3178401v1.0 - ACOSOG-Z4099 Pretreatment RECIST Measurement Form (Arm 2)

- 09/01/15 - 1 modulo, 3 itemgroups, 11 elementi, 1 linguaggio
Itemgroups: Header Module, Visit, Pretreatment Measurement
ACOSOG-Z4099 Pretreatment RECIST Measurement Form (Arm 2) Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=986988FF-3289-FDB7-E040-BB89AD4317E3

Lung Cancer NCT01336894 Response - ACOSOG-Z4099 Active Monitoring RECIST Measurement Form (Arm 2) - 3178204v1.0 - ACOSOG-Z4099 Active Monitoring RECIST Measurement Form (Arm 2)

- 09/01/15 - 1 modulo, 4 itemgroups, 13 elementi, 1 linguaggio
Itemgroups: Header Module, Visit, Overall Response Status, Active Monitoring Measurement
ACOSOG-Z4099 Active Monitoring RECIST Measurement Form (Arm 2) Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9815654D-3AFA-EB3D-E040-BB89AD437C70

Southwest Oncology Group Follow-Up Tumor Assessment Form

- 03/07/15 - 1 modulo, 7 itemgroups, 26 elementi, 1 linguaggio
Itemgroups: SWOG clinical trial administrative data, Target Lesions, Non-target Disease, New Lesions, Symptomatic deterioration, Comments, CCRR MODULE
Southwest Oncology Group Follow-Up Tumor Assessment Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A50B6C19-55BD-164C-E034-080020C9C0E0

CALGB 30506 Treatment And Response Form NCT00863512

- 12/06/15 - 1 modulo, 7 itemgroups, 25 elementi, 1 linguaggio
Itemgroups: Header Module, Patient demographics, Patient Data, First Treatment (cycles 1 ¿ 6), Dose Modifications, Reason Treatment Ended, Footer Module
CALGB 30506 Treatment And Response Form NCT00863512 Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5E92C67F-DAF6-CFB0-E040-BB89AD432DA1

SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM NCT00045162

- 09/06/15 - 1 modulo, 6 itemgroups, 24 elementi, 1 linguaggio
Itemgroups: Header, TARGET LESIONS, NON-TARGET DISEASE, NEW LESIONS (specify site), Symptomatic deterioration, Comments
SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM NCT00045162 S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=001B724F-E7F0-4714-E044-0003BA3F9857

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial